The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Giannini Daniel A since 2010.
The trader's CIK number is 1341402.
At the time of the last reporting, Giannini Daniel A was the Director of Nxstage Medical, Inc.. (stock ticker symbol NXTM).
Also see all insider trading activities at Nxstage Medical, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | NXTM | 0 | $0 | 0 | $0 | 18,196 | $247,465 |
| 2016 | NXTM | 0 | $0 | 6,449 | $167,416 | 29,272 | $488,627 |
| 2015 | NXTM | 0 | $0 | 6,593 | $133,837 | 14,000 | $194,320 |
| 2014 | NXTM | 0 | $0 | 0 | $0 | 14,000 | $47,320 |
| 2013 | NXTM | 0 | $0 | 0 | $0 | 14,000 | $75,460 |
| 2012 | NXTM | 0 | $0 | 0 | $0 | 14,000 | $170,800 |
| 2011 | NXTM | 0 | $0 | 0 | $0 | 14,000 | $151,620 |
| 2010 | NXTM | 0 | $0 | 0 | $0 | 15,000 | $188,850 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-05-17 | NXTM | Option Ex | 18,196 | 13.60 | 247,465 |
| 2016-11-21 | NXTM | Sale | 6,449 | 25.96 | 167,416 |
| 2016-08-04 | NXTM | Option Ex | 15,272 | 14.99 | 228,927 |
| 2016-05-25 | NXTM | Option Ex | 14,000 | 18.55 | 259,700 |
| 2015-11-09 | NXTM | Sale | 6,593 | 20.30 | 133,837 |
| 2015-03-13 | NXTM | Option Ex | 14,000 | 13.88 | 194,320 |
| 2014-01-02 | NXTM | Option Ex | 14,000 | 3.38 | 47,320 |
| 2013-03-12 | NXTM | Option Ex | 14,000 | 5.39 | 75,460 |
| 2012-03-14 | NXTM | Option Ex | 14,000 | 12.20 | 170,800 |
| 2011-03-11 | NXTM | Option Ex | 14,000 | 10.83 | 151,620 |
| 2010-08-13 | NXTM | Option Ex | 15,000 | 12.59 | 188,850 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Giannini Daniel A (Director of Nxstage Medical, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.